Mesenchymal Cell News Volume 2.21 | Jun 1 2010

    By
    Justin.choi
    -
    0
    30

    Mesenchymal Cell News 2.21, June 1, 2010.
    In this issue: Science News  |  Current Publications  |  Industry News  |  Policy News  |  EventsSubscribe  |  Unsubscribe

    TOP STORY

    Stem Cell Disruption Induces Skull Deformity, UR Study Shows
    Scientists discovered a defect in cellular pathways that provides a new explanation for the earliest stages of abnormal skull development in newborns, known as craniosynostosis. [Press release from the University of Rochester Medical Center discussing online prepublication in Science Signaling]

    Aldefluor_645x110_v01

    SCIENCE NEWS

    New Source of Stem Cells Form Heart Muscle Cells, Repair Damage
    Investigators in Japan used the amniotic membrane to obtain human amniotic membrane-derived mesenchymal cells. [Press release from ScienceDaily discussing online prepublication in Circulation Research]

    UA Doctor Studies Stem Cell Use in Cardiac Recovery
    A Tucson cardiologist is part of a national trial that’s testing whether human mesenchymal stem cells can help repair the hearts of people who have just suffered heart attacks. [Arizona Daily Star]

    microscope 

    Learn about our GLP compliant Contract Assay Services

    WATCH THE VIDEO
    		 
     
    WWW.CONTRACTASSAY.COM | WWW.STEMCELL.COMSTEMCELL Technologies Inc
    		 

    CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)

    The Balance of WNT and FGF Signaling Influences Mesenchymal Stem Cell Fate During Skeletal Development
    Here, researchers show that endochondral ossification, a type of bone formation that proceeds through a cartilage intermediate, caused by switching the fate of mesenchymal stem cells to chondrocytes, can also result in craniosynostosis. [Sci Signal]

    Xenografted Human Amniotic Membrane-Derived Mesenchymal Stem Cells Are Immunologically Tolerated and Transdifferentiated Into Cardiomyocytes
    The objective of this study was to determine whether human amniotic membrane-derived mesenchymal cells can be an ideal allograftable stem cell source for cardiac regenerative medicine. [Circ Res]

    Mesenchymal Stem Cells Inhibit Human Th17 Cell Differentiation and Function and Induce a T Regulatory Cell Phenotype
    Because of the deleterious role of Th17 cells in the pathogenesis of inflammatory disease, researchers investigated whether proinflammatory cytokines could modify the expression of adhesion molecules on human mesenchymal stem cells (MSCs), thereby contributing to increased Th17 cell adhesion to MSCs and, as a consequence, modulating the function of the latter cells. [J Immunol]

    Tumor Cell Behaviour Modulation by Mesenchymal Stromal Cells
    Researchers aimed to show whether multipotent mesenchymal stromal cells derived from human adipose tissue could create tumor cell-protective milieu and affect tumor cell behaviour in vitro and in vivo. [Mol Cancer]

    shRNA-Mediated Decreases in c-Met Levels Affect the Differentiation Potential of Human Mesenchymal Stem Cells and Reduce Their Capacity for Tissue Repair
    The current study highlights the significance of HGF/c-Met signaling in the capacity of mesenchymal stem cells to restore blood flow after an ischemic injury and in their ability to differentiate into the osteogenic and chondrogenic lineages. [Tissue Eng Part A]

    High-Efficiency Transduction of Fibroblasts and Mesenchymal Stem Cells by Tyrosine-Mutant AAV2 Vectors for Their Potential Use in Cellular Therapy
    In the current studies, researchers evaluated the transduction efficiency of single as well as multiple tyrosine-mutant adeno-associated virus 2 (AAV2) vectors in murine fibroblasts. [Hum Gene Ther]

    INDUSTRY NEWS

    DFG Approves 12 New Collaborative Research Centers
    The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has approved the establishment of twelve new Collaborative Research Centers. [Dutch Research Foundation Press Release]

    t2cure First Company to Have Quality of Cellular Therapeutic Certified by EMA
    t2cure GmbH announced that the quality of its lead product t2c001 has been certified by the European Medicines Agency (EMA). t2c001 is the first product ever to obtain a certificate under the EMA regulations for Advanced Therapy Medicinal Products. [t2cure GmbH Press Release]

    Glycosan BioSystems Seeks CE Mark in the European Union for HyStem-Rx, a Unique, Implantable Scaffold for Tissue Engineering
    Glycosan BioSystems announced that the Company has begun the process for gaining regulatory approval within the European Union for the use of HyStem-Rx as a resorbable scaffold for implanting autologous adipose derived cells in reconstruction and aesthetic plastic surgery procedures. [PR Newswire]

    POLICY NEWS

    Treasury Releases New Guidance for Tax Credit in Affordable Care Act to Support Groundbreaking Biomedical Research
    The U.S. Department of the Treasury announced the guidelines for applying for the new Therapeutic Discovery Project Program created by the Affordable Care Act. [Department of the Treasury, United States]

    Third Time’s a Charm for COMPETES Bill
    By a vote of 262 to 150, legislators authorized $84 billion for research, education, and innovation programs over the next 5 years at the National Science Foundation, the Department of Energy, and two Department of Commerce agencies – NOAA and NIST under the America COMPETES Reauthorization Act (HR 5116). [House of Representatives, United States]

    Democrats: FDA Should Be Able to Recall Drugs
    House Democrats repeatedly called for federal regulators to be given the authority to recall drugs. Pending legislation would grant that power to the Food and Drug Administration (FDA) for food, but not for drugs. [House of Representatives, United States]

    Last Hurrah from National Academies Stem Cell Committee
    Even though the National Institutes of Health issued stem cell guidelines last year, there’s still a need for guidelines for research that remains off-limits for U.S. government-funded labs. [National Academies’ National Research Council and Institute of Medicine, United States]

    NIH Set to Tighten Financial Rules for Researchers
    After a wave of financial scandals over the past few years involving biomedical researchers, the U.S. National Institutes of Health (NIH) proposed far-reaching changes that would lead to tighter oversight of agency-funded extramural investigators and their institutions. [National Institutes of Health, United States]

    Request for Information (RFI) on the NIH Plan to Develop the Genetic Testing Registry (NOT-OD-10-101)
    [National Institutes of Health, United States]

    Administrative Supplements to Advance Special Translational Research Acceleration Projects on Immune Response Modifiers Currently Funded by the National Cancer Institute (NCI) (NOT-CA-10-025) [National Institutes of Health, United States]

    Exceptions and Alternative Procedures Approved Under 21 CFR 640.120 [Food and Drug Administration, United States]

    EVENTS

    Tissue Engineering & Regenerative Medicine International Society (TERMIS) – European Union 2010
    June 13-17, 2010
    Galway, Ireland

    International Society for Stem Cell Research (ISSCR) 8th Annual Meeting
    June 16-19, 2010
    San Francisco, United States

    United Kingdom National Stem Cell Network (UKNSCN) 3rd Annual Scientific Conference
    July 12-14, 2010
    Nottingham, United Kingdom

    Tissue Engineering & Regenerative Medicine International Society (TERMIS) – Asia Pacific 2010
    September 15-17, 2010
    Sydney, Australia

    5th World Congress on Preventative and Regenerative Medicine (WCRM) 2010
    October 5-7, 2010
    Hannover, Germany

    2010 American Society for Matrix Biology (ASMB) Meeting
    October 24-27, 2010
    Charleston, United States

    52nd American Society of Hematology (ASH) Annual Meeting and Exposition
    December 4-7, 2010
    Orlando, United States

    Tissue Engineering & Regenerative Medicine International Society (TERMIS) – North America 2010 Annual Conference
    December 5-8, 2010
    Orlando, United States

    Visit our events page  to stay up to date with the latest events in the cell, gene and immunotherapy community.

    JOB OPPORTUNITIES

    Senior Scientist – Magnetic Cell Separation (STEMCELL Technologies)

    Business Development Manager Europe – Cell Therapy Products (Pall Corporation)

    Manager/Sr. Manager, Therapeutic Cell Solutions, Process Development (Lonza)

    Sr. Product Support and Training Specialist (CardianBCT)

    Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Mesenchymal Cell News.

    Visit here to post your career opportunities.


    Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!



    Comments or Suggestions? Email info@connexoncreative.com with your feedback.


    Learn more about Mesenchymal Cell News: Archives  |  Events  |  Subscribe  |  Contact Us